Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
T.MDP
Alternate Symbol(s):
MEDXF
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its...
lead products are IXINITY (US), Rupall (Canada), Rasuvo (US) and Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3572)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 04, 2023 10:58am
New..Scintillating Growth, growing profitability, solid cash
Medexus Pharmaceuticals Inc Symbol MDP Shares Issued 20,139,018 Close 2023-07-12 C$ 1.85
...more
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Jul 12, 2023 11:09pm
Let’s see what the market
Let’s see what the market says. Start trading under 1.80, we can see a rollover in the stock price.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 12, 2023 5:31pm
New Press Release - Medexus Announces Preliminary Revenue for Fiscal Q1 2024
Preliminary estimates indicate revenue is expected to exceed US$31 million for fiscal quarter ended June 30, 2023Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - July 12, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for...
read article.
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Jul 06, 2023 3:27pm
RE:Good chance
Nice pull back, right down to the 50% retracement pretty much and filled in the gap too.
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Jul 04, 2023 6:38pm
Good chance
Good chance we pull back from this rally. From the low of 1.27 to high of 2.25 today. Daily Fibonacci retracement will be 38.2%~$1.88, 50% ~1.76$ or last would be 61.8% ~ 1.64 range
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Jun 30, 2023 12:03pm
RE:Fibonacci retracement on weekly chart
There a big magnet at the Fibonacci retracement 61.8 area where the big gap happened in 2021. That could be the top of this run,5.50 to $6.20 area
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Jun 29, 2023 1:53pm
Fibonacci retracement on weekly chart
Fibonacci retracement on weekly chart From the 2021 high to 2022 low should be.... 38.2% 4.20$ 50% 5.18$ 61.8% 6.20
(3)
•••
existabo
X
View Profile
View Bullboard History
Comment by
existabo
on Jun 23, 2023 11:51am
RE:RE:RE:RE:October 16, 2023
look up Simply Wall Street, independant ( no broker) site that give fair valuation . Back to the chart ,we need good to great volume for a decent breakout.
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Jun 22, 2023 6:52pm
RE:RE:RE:October 16, 2023
RSI at the same point in Oct 22ish, before it doubled in price. Volume is great too. MACD has been climbing positive since start of May. nice
(3)
•••
existabo
X
View Profile
View Bullboard History
Comment by
existabo
on Jun 22, 2023 4:15pm
RE:RE:October 16, 2023
On top of great results and financial strength, broker are going to look for action on M&A and ask their analyst to write it up. We need new buyer to push the 50 day moving aver. back up
...more
(4)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Jun 22, 2023 1:30pm
RE:October 16, 2023
They will have $20ish million in cash plus $20 million credit line in October when the $34 million in debentures come due. Plus buying back 10% of the convertible debt before October. Finally
...more
(2139)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 22, 2023 10:31am
October 16, 2023
$34 million of debentures comes due.
(3)
•••
existabo
X
View Profile
View Bullboard History
Post by
existabo
on Jun 22, 2023 9:50am
Amazing results
WOW, we are on our way to a new high, working on all ciylinder, fundamental, great chart and Treo coming later to booth. should see good volume from new players soon
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jun 13, 2023 3:37pm
Very good news for MDP in Canada
Medexus Pharmaceuticals (MDP.T) has a boatload of pharma IP in the guise of numerous drug treatments that bring in excess of US$100m per year in revenues, which we like a lot on a US$17m market cap.
...more
(18)
•••
GoldenArm1
X
View Profile
View Bullboard History
Post by
GoldenArm1
on Feb 28, 2023 4:24pm
Back on and MDP
Any reason why Yahoo is showing the stock was halted on 23rd?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >